Financial
Listed (6965.T).
Latest full-year results not yet captured by HSH.
Hamamatsu Photonics
HQ Japan · Asia-Pacific
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
At a glance
Financial health
Band: Not assessed
Customer rating
No reviews yet
Financial health
Band: Not assessedListed: 6965.T
Listed (6965.T).
Latest full-year results not yet captured by HSH.
Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
Products & services
Products not yet catalogued.
Risk summary
Full risk page with sources →Researched 8 Nov 2026
Adverse media
No adverse media involving Hamamatsu Photonics found in HSH's search of the last 24 months.
Cyber & information governance
No data breaches, cyber incidents or regulator action involving Hamamatsu Photonics found in HSH's search of the last 24 months. NHS DSPT status not yet checked.
Regulatory & clinical safety
No product recalls, safety notices or warning letters involving Hamamatsu Photonics' NanoZoomer digital pathology scanners found in HSH's search of the last 24 months.
Contract performance
No notable contract disputes, terminations or troubled implementations involving Hamamatsu Photonics found in HSH's search of the last 24 months.
Competitors
No competitors linked yet.